There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

The company’s PulseSelect PFA catheter is scaling up ... An advisory panel backed the former, but recommended against approval of the latter. Globus Medical and Thermo Fisher were among the companies ...

The Kremlin earned some €3 billion in 2023 in tax from European Union companies that were, and sometimes still are, active in ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Globus Medical (NYSE:GMED – Free Report) had its target price increased by Canaccord Genuity Group from $92.00 to $101.00 in ...

Needham & Company LLC reissued their hold rating on shares of Globus Medical (NYSE:GMED – Free Report) in a research note published on Thursday,Benzinga reports. Several other brokerages have also ...

Globus Medical Inc (GMED) stock saw a modest uptick, ending the day at $87.07 which represents a slight increase of $0.52 or 0.60% from the prior close of $86.55. The stock opened at $88.5 and touched ...

Biotech stock GeneDx broke out after the FDA issued its first AI rules for medical devices. Globus Medical and GeneDx are in ...

Two oil and gas stocks hit 52-week highs as energy prices popped Friday. The stocks are in buy zones while a medical device ...

Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

在其他近期新闻中，Globus Medical因其强劲的第四季度收入和积极的2025年展望而受到各方分析师的关注。公司报告第四季度销售额为6.57亿美元，超过了市场预期。2024年全年销售额也大幅增长，达到约25.2亿美元。

Leishen Energy Holding Co., Ltd. (the "Company”), (Nasdaq: LSE), a China-based provider of clean-energy equipment and ...